导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.95% | 823/1050 |
| 近一周 | -2.48% | 625/1104 |
| 近一月 | -4.68% | 575/1102 |
| 近一季 | -23.65% | 1031/1092 |
| 近半年 | -11.60% | 807/1070 |
| 近一年 | -17.89% | 861/1018 |
| 近两年 | 25.70% | 722/926 |
| 近三年 | -3.10% | 700/834 |
| 成立以来 | -28.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.12% 827/1070 |
36.73% 279/1101 |
- - |
- - |
| 2025 | 22.68% 621/1065 |
7.13% 275/1014 |
9.81% 109/1038 |
16.76% 703/1050 |
-10.69% 899/1065 |
| 2024 | -3.63% 664/1011 |
-1.26% 386/960 |
-4.27% 588/983 |
7.59% 796/991 |
-5.24% 685/1011 |
| 2023 | -23.72% 756/952 |
-1.56% 688/880 |
-4.26% 473/895 |
-12.09% 685/915 |
-7.93% 751/952 |
| 2022 | -27.25% 561/867 |
-21.23% 591/773 |
11.02% 226/806 |
-21.14% 769/845 |
5.49% 180/867 |
| 2021 | -6.96% 449/740 |
-2.72% 253/580 |
14.77% 240/659 |
-9.56% 497/704 |
-7.85% 632/740 |
| 2020 | - - |
- - |
- - |
- - |
16.62% 176/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中银内核驱动股票A VS. 东吴新产业精选股票A(580008) |